Concepedia
Statistics
Publications
1
Citations
30
H-Index
Active since
2011
D. Caramazza is an author specializing in medicine, molecular medicine, and antifibrotic therapy.
Top concepts
HealthMedicineOncologyHematologyImmunologyThrombosisPharmacologyClinical TrialsPharmacotherapyMolecular Medicine
Publications per year
2011–2011
Safety and efficacy of CYT387, a JAK-1/2 inhibitor, for the treatment of myelofibrosis.
Animesh Pardanani, D. Caramazza, Gemlyn George et al. · Journal of Clinical Oncology · 2011 · 30 citations
Hematological Malignancy, Thrombosis, Therapeutic Drug Monitoring +15
1–1 of 1